Perioperative Thrombotic Risk Guide for Hematology Fellows
Chokri Ben Lamine, Adult Hematology and Stem Cell Transplantation Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital & Research Center, shared a post on X:
“Perioperative Thrombotic Risk – Quick Guide for Hema Fellows
High Risk (>10%/mo VTE or >10%/yr ATE)
Recent (<3 mo) VTE
Strong thrombophilia (Protein C/S def., ATIII def., homozygous FVL/PGM, multiple thrombophilias)
APS
High-risk cancer: pancreas, brain, stomach, esophagus, myeloproliferative
AF: CHA₂DS₂-VASc ≥7, recent (<3 mo) stroke/TIA, rheumatic valve
Mechanical valve: MVR w/ major stroke RF, caged-ball/tilting-disc (any position), recent stroke/TIA
Moderate Risk (4–10%/mo VTE or 4–10%/yr ATE)
VTE within 3–12 mo
Recurrent VTE
Non-strong thrombophilia (heterozygous FVL/PGM)
Non-high-risk cancer VTE
AF: CHA₂DS₂-VASc 5–6
Mechanical valve: MVR w/o major stroke RF, bileaflet AVR w/ major stroke RF
Low Risk (<4%/mo VTE or <4%/yr ATE)
VTE >12 mo ago
AF: CHA₂DS₂-VASc 1–4
Mechanical valve: bileaflet AVR w/o major stroke RF
MCQ
Q: A 65-year-old with AF (CHA₂DS₂-VASc = 6) and VTE 8 months ago is scheduled for elective surgery. Perioperative thrombotic risk?
A) High
B) Moderate
C) Low
Answer: B) Moderate
Explanation: CHA₂DS₂-VASc = 6 → moderate AFib risk; VTE within 3–12 months → moderate VTE risk.
OSCE Scenario
Station: Pre-op anticoagulation planning for high-risk VTE
Prompt: 55-year-old with recent (<3 mo) DVT on warfarin, elective colectomy scheduled.
Tasks:
Identify thrombotic risk category (High)
Discuss bridging anticoagulation plan with LMWH
Outline timing for last LMWH dose before surgery and restart post-op
Counsel on bleeding vs thrombosis risk
Key points for examiner:
Recognize high risk → needs bridging
Stop warfarin 5 days pre-op
Last therapeutic LMWH 24 h pre-op
Credits to ASH SAP 9th edition ”
Stay updated with Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25